# Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)

> **NCT00656409** · PHASE3 · COMPLETED · sponsor: **Institute of Child Health** · enrollment: 30 (actual)

## Conditions studied

- Ataxia Telangiectasia (AT)

## Interventions

- **DRUG:** Conjugated pneumococcal vaccine (Prevenar)

## Key facts

- **NCT ID:** NCT00656409
- **Lead sponsor:** Institute of Child Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** 2008-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00656409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00656409, "Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00656409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*